Return On Equity of Compass Therapeutics, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Compass Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Compass Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -49%, a 51% decline year-over-year.
  • Compass Therapeutics, Inc. annual Return On Equity for 2024 was -35%, a 34% decline from 2023.
  • Compass Therapeutics, Inc. annual Return On Equity for 2023 was -26%, a 7.1% increase from 2022.
  • Compass Therapeutics, Inc. annual Return On Equity for 2022 was -28%, a 81% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Compass Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -49% -17% -51% 01 Jul 2025 30 Sep 2025
Q2 2025 -53% -22% -72% 01 Apr 2025 30 Jun 2025
Q1 2025 -42% -14% -48% 01 Jan 2025 31 Mar 2025
Q4 2024 -35% -8.8% -34% 01 Oct 2024 31 Dec 2024
Q3 2024 -32% -8.6% -36% 01 Jul 2024 30 Sep 2024
Q2 2024 -31% -4.3% -16% 01 Apr 2024 30 Jun 2024
Q1 2024 -29% -2.1% -7.8% 01 Jan 2024 31 Mar 2024
Q4 2023 -26% +2% +7.1% 01 Oct 2023 31 Dec 2023
Q3 2023 -24% +7.6% +24% 01 Jul 2023 30 Sep 2023
Q2 2023 -27% +5.9% +18% 01 Apr 2023 30 Jun 2023
Q1 2023 -27% +74% +73% 01 Jan 2023 31 Mar 2023
Q4 2022 -28% +117% +81% 01 Oct 2022 31 Dec 2022
Q3 2022 -31% +215% +87% 01 Jul 2022 30 Sep 2022
Q2 2022 -33% +183% +85% 01 Apr 2022 30 Jun 2022
Q1 2022 -100% -30% -43% 01 Jan 2022 31 Mar 2022
Q4 2021 -145% +605% +81% 01 Oct 2021 31 Dec 2021
Q3 2021 -246% -1259% -124% 01 Jul 2021 30 Sep 2021
Q2 2021 -216% -291% -389% 01 Apr 2021 30 Jun 2021
Q1 2021 -70% -113% -263% 01 Jan 2021 31 Mar 2021
Q4 2020 -750% -804% -1514% 01 Oct 2020 31 Dec 2020
Q3 2020 1013% +974% +2520% 01 Jul 2020 30 Sep 2020
Q2 2020 75% +21% +39% 01 Apr 2020 30 Jun 2020
Q1 2020 43% -41% -49% 01 Jan 2020 31 Mar 2020
Q4 2019 53% -75% -59% 01 Oct 2019 31 Dec 2019
Q3 2019 39% 01 Jul 2019 30 Sep 2019
Q2 2019 54% 01 Apr 2019 30 Jun 2019
Q1 2019 84% 01 Jan 2019 31 Mar 2019
Q4 2018 128% 01 Oct 2018 31 Dec 2018

Compass Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -35% -8.8% -34% 01 Jan 2024 31 Dec 2024
2023 -26% +2% +7.1% 01 Jan 2023 31 Dec 2023
2022 -28% +117% +81% 01 Jan 2022 31 Dec 2022
2021 -145% +605% +81% 01 Jan 2021 31 Dec 2021
2020 -750% -797% -1721% 01 Jan 2020 31 Dec 2020
2019 46% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.